Down 38.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Cyclerion Therapeutics, Inc. (CYCN)

Published on December 15, 2021

The heavy selling pressure might have exhausted for Cyclerion Therapeutics, Inc. (CYCN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall...

Continue reading on website
Other news

Down 35.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Mesoblast Limited (MESO)

December 15, 2021
The heavy selling pressure might have exhausted for Mesoblast Limited (MESO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street...

E-commerce marketplace The List checks off new funding, new app

December 15, 2021
The List joins the social commerce movement with a new app connecting consumers with global luxury brands and retailers to offer a personalized discovery and shopping experience.Focused on sourcing hard-to-find items, the app launch is buoyed by $3.5 million in seed funding backed by a group including American Designer and Rachel Zoe, who is both an investor and advisor to the New York-based compa